Shanghai Electric Group and Siemens Healthineers Unveil Ultramarine Series Medical Imaging Devices
Shanghai Electric Group, a major player in China’s electrical equipment industry, has partnered with Siemens...
JD Healthcare Forges Partnerships with Top Medical Device Firms at CMEF
The China International Medical Equipment Fair (CMEF), which took place last week in Shanghai, was...
FDA Advisory Committee Backs MRD as Accelerated Approval Endpoint for Multiple Myeloma
The Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration (FDA) has...
I-Mab CEO Outlines Streamlined US Entity’s Focus and Potential for In-Licensing
I-Mab (NASDAQ: IMAB), a biopharmaceutical company that recently restructured into separate US and Chinese entities,...
Hainan Medical Zone Launches ‘Lecheng Global Special Medical Insurance’ for Wider Drug Access
The Hainan Boao Lecheng International Medical Tourism Pilot Zone has launched the “Lecheng Global Special...
Hengrui Pharmaceuticals Gets NMPA Approval for Clinical Study of CDK 4/6 Inhibitor Combo in Breast Cancer
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a prominent pharmaceutical company in China, has announced...
Blue Shield Biotech Faces Bankruptcy Proceedings After Missing Debt Payments
The Nanjing Qixia District People’s Court has accepted a bankruptcy liquidation case for Blue Shield...
Roche and Eli Lilly’s Elecsys pTau217 Blood Test Earns FDA Breakthrough Designation for Alzheimer’s Detection
The U.S. Food and Drug Administration (FDA) has granted a breakthrough device designation for Elecsys...
3SBio Secures NMPA Approval for Pediatric Thrombopoietin Treatment of ITP
3SBio Inc. (HKG: 1530), a leading biopharmaceutical company based in China, has announced that it...
Bayer Partners with Hologic to Develop Contrast-Enhanced Mammography Solution for Breast Cancer Diagnosis
Bayer (ETR: BAYN), a multinational pharmaceutical and life sciences company headquartered in Germany, has announced...
AbbVie’s Aquipta/Qulipta Shows Promise in Migraine Prevention Trial
AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, last week released interim results from a...
Laekna’s Anti-ActRIIA Antibody LAE102 Clears FDA Hurdle for Obesity Treatment Trial
Sino-American biotech firm Laekna has announced that it has received clinical trial approval from the...
NHSA Reports 2023 Milestones in Basic Medical Insurance Participation and Financials
The National Healthcare Security Administration (NHSA) has published its annual “Healthcare Security Development Statistical Bulletin”...
Sanofi Explores Sale of Amunix Pharmaceuticals as It Shifts Focus to Immunology
Sanofi (NASDAQ: SNY), the France-based pharmaceutical giant, is reportedly in talks with potential buyers for...
AstraZeneca’s Fasenra Gains FDA Approval for Pediatric Severe Asthma Treatment
AstraZeneca (AZ; NASDAQ: AZN) has secured an indication extension from the U.S. Food and Drug...
Qilu Pharmaceutical Gets NMPA Green Light for Generic Romiplostim for ITP Treatment
The National Medical Products Administration (NMPA) in China has granted marketing approval to Qilu Pharmaceutical...
Suzhou Zelgen Receives NMPA Approval for Jacktinib Cream Trial in Vitiligo Patients
Suzhou Zelgen Biopharmaceuticals Co., Ltd (SHA: 688266) has announced that it has received approval from...
Haisco Pharmaceutical Gets NMPA Green Light for HSK31858 COPD Trial
Haisco Pharmaceutical Group Co., Ltd (SHE: 002653), a Chinese pharmaceutical company, has announced that it...
Vertex Pharmaceuticals to Acquire Alpine Immune Sciences in a $4.9 Billion Deal
In a multibillion-dollar deal within the biotechnology sector, Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a leader...
Teva’s Ajovy Achieves Positive Results in Phase III Migraine Prevention Trial in China
Teva Pharmaceutical Industries Ltd (NYSE: TEVA), headquartered in Israel, has announced positive results from a...